Gan & Lee Reports Positive Clinical Results for Di...
Category : Clinical Trial Update 13 June 2026Company Announces Progress in Phase 3 Studies of Insulin Ludefen and Bofanglutide Gan & Lee P...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Belite Bio Completes NDA Submission for Tinlareban...
Category : Clinical Trial Update 13 June 2026Belite Bio Reaches Important Regulatory Milestone Belite Bio has announced the completion of its...
Takeda Reports Positive Phase 3 Results for Zasoci...
Category : Clinical Trial Update 13 June 2026Takeda has announced positive topline results from its Phase 3 LATITUDE Atlas study evaluating zasoc...
Johnson & Johnson Reports Positive Phase 2/3 Resul...
Category : Clinical Trial Update 12 June 2026ENERGY Study Shows Significant Hemoglobin Improvement in Patients with Rare Blood Disorder Johnso...
Lateral Pharma Highlights New Therapeutic Target f...
Category : Clinical Trial Update 12 June 2026Study Published in PAIN Journal Identifies LanCL1 as a Potential Target for Chronic Nerve Pain Treat...
Latest Newsletter Post
-
Takeda Reports Positive Phase 3 Res..
13 June 2026
-
Belite Bio Completes NDA Submission..
13 June 2026
-
Gan & Lee Reports Positive Clinical..
13 June 2026
-
Novartis Reports Positive FORTITUDE..
12 June 2026
-
Lateral Pharma Highlights New Thera..
12 June 2026
